Clinical Trial Update: Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on extended low-molecular-weight heparin for VTE prophylaxis in thoracic surgery shows completed status; assesses prevention of venous th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasms
• Pulmonary Embolism
• Venous Thromboembolism

Snippet

Sponsor: McMaster University | Conditions: Venous Thromboembolism, Lung Neoplasms | Phase 1, Phase 2 | Status: COMPLETED